PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.
about
Animal models of peripheral neuropathiesLipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenalParp inhibition prevents ten-eleven translocase enzyme activation and hyperglycemia-induced DNA demethylationTargeting apoptosis signalling kinase-1 (ASK-1) does not prevent the development of neuropathy in streptozotocin-induced diabetic mice.Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury.Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathyTriglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress.Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita miceMetanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats.Exercise alleviates hypoalgesia and increases the level of calcitonin gene-related peptide in the dorsal horn of the spinal cord of diabetic rats.12/15-Lipoxygenase inhibition counteracts MAPK phosphorylation in mouse and cell culture models of diabetic peripheral neuropathy.Poly (ADP-ribose) polymerase mediates diabetes-induced retinal neuropathy.Intracellular TRPA1 mediates Ca2+ release from lysosomes in dorsal root ganglion neurons.Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy.Quercetin protects rat dorsal root ganglion neurons against high glucose-induced injury in vitro through Nrf-2/HO-1 activation and NF-κB inhibitionDiabetic neuropathy: cellular mechanisms as therapeutic targets.Reactive aldehydes--second messengers of free radicals in diabetes mellitus.Cell therapy for diabetic neuropathy using adult stem or progenitor cells.PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?Effects of stimulation of autophagy on the urinary excretion of biomarkers of the oxidative status.Intraperitoneal Administration of Oxygen/Ozone to Rats Reduces the Pancreatic Damage Induced by Streptozotocin.Oxaliplatin-induced enteric neuronal loss and intestinal dysfunction is prevented by co-treatment with BGP-15.Methamphetamine Induces TET1- and TET3-Dependent DNA Hydroxymethylation of Crh and Avp Genes in the Rat Nucleus Accumbens.Dual effect of methylglyoxal on the intracellular Ca2+ signaling and neurite outgrowth in mouse sensory neurons.Oxidative status of cardinal ligament in pelvic organ prolapse
P2860
Q27028046-CA994CFE-4F2C-4577-897C-1278B907B04EQ33790988-E0ECEFD3-4B4D-442E-A94E-EF1EA5357794Q34077381-BE87D944-1145-495B-8E36-2CCFD90E3F8BQ35346731-CCB14764-C3E9-4C3E-8961-D70EB7B2076DQ35514172-52479896-F161-4343-8772-859C3BD96BC5Q35784340-F215183C-76E8-4AA4-9DB3-5DD0EDF12304Q35854702-E8BFFBDB-DE8E-432E-A4E5-F3B487469DD5Q36032110-F45F94F7-8C81-4512-8C8E-8D20767BD7D8Q36109233-F9F59700-EE29-44D7-AF05-A304BABC87B0Q36223018-E3E99E62-DB79-4473-9C05-D4AC2362AA15Q37257009-EC9D1E1C-E09F-4CD5-89F3-069F33702A11Q37379837-DAE14A30-E71B-4D33-8EA2-ED71B88098C7Q37400839-A6FC7389-612B-4CA3-AE0B-4EB7CFA8862EQ37541146-BEEE5969-CB1D-4508-AA39-9B7BC7A64075Q37729575-A723006B-F497-45B7-A5C5-5F392D5ED7EFQ37930962-A8732183-8DD6-45A3-9210-11F6880D27BDQ38092186-D5CF6393-D3A6-404C-ABC8-213CAA6F313AQ40178258-6832B862-C048-46BD-B18C-8B13945F0462Q42107975-90803CD0-3ED6-410B-B9E8-B61C73D1A5C8Q46783933-DDFC7652-7F54-4BE5-91F2-70F461C720A1Q47556874-A8488B9F-2AB4-4D89-89FF-426D9C32DB62Q47773940-C3D5EF3B-1B5A-44D6-83C8-3F7BF5762541Q47903195-18D8E353-1132-42D3-B9FE-5914D6A298B9Q53647617-79D1DFE8-2B31-4F3A-9CBA-74331634926EQ58726639-9C1EB16E-C79D-47D7-B0BF-29C451D85211
P2860
PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
PARP inhibition alleviates dia ...... ith peripheral nerve function.
@ast
PARP inhibition alleviates dia ...... ith peripheral nerve function.
@en
PARP inhibition alleviates dia ...... ith peripheral nerve function.
@nl
type
label
PARP inhibition alleviates dia ...... ith peripheral nerve function.
@ast
PARP inhibition alleviates dia ...... ith peripheral nerve function.
@en
PARP inhibition alleviates dia ...... ith peripheral nerve function.
@nl
prefLabel
PARP inhibition alleviates dia ...... ith peripheral nerve function.
@ast
PARP inhibition alleviates dia ...... ith peripheral nerve function.
@en
PARP inhibition alleviates dia ...... ith peripheral nerve function.
@nl
P2093
P2860
P1476
PARP inhibition alleviates dia ...... ith peripheral nerve function.
@en
P2093
Hanna Shevalye
Irina G Obrosova
Sergey Lupachyk
Viktor R Drel
Yury Maksimchyk
P2860
P304
P356
10.1016/J.FREERADBIOMED.2011.01.037
P577
2011-02-24T00:00:00Z